Background Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease worldwide. Many individuals have risk factors associated with NAFLD, but the …

Although overall donation and transplantation activity is higher in Europe than on other
continents, differences between European countries in almost every aspect of …

Cholestatic and non-alcoholic fatty liver disease (NAFLD) share several key
pathophysiological mechanisms which can be targeted by novel therapeutic concepts that …

Despite its increased recognition as a major health threat, fatty liver disease associated with
metabolic dysfunction remains largely underdiagnosed and undertreated. An international …

Background & Aims Little is known about outcomes of liver transplantation for patients with
non-alcoholic steatohepatitis (NASH). We aimed to determine the frequency and outcomes …

As morbidity and mortality related to potentially preventable liver diseases are on the rise
globally, early detection of liver fibrosis offers a window of opportunity to prevent disease …

The promise of regenerative medicine and tissue engineering is founded on the ability to
regenerate diseased or damaged tissues and organs into functional tissues and organs or …

Background and Aims Interleukin‐22 has beneficial effects on inflammation and impaired
hepatic regeneration that characterize alcohol‐associated hepatitis (AH). F‐652 is a …

Background & Aims Although treatment of hepatitis C virus (HCV) infection has improved,
the prevalence of alcoholic liver disease (ALD) has been increasing, so we need an …

The rising tide of non-alcoholic fatty liver disease (NAFLD) associated with the obesity
epidemic is a major health concern worldwide. NAFLD—specifically its more advanced form …